PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 209 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,936,933 | +62.7% | 487,135 | +66.1% | 0.00% | 0.0% |
| Q1 2024 | $8,568,239 | -22.5% | 293,232 | -10.5% | 0.00% | 0.0% |
| Q4 2023 | $11,053,426 | +14.8% | 327,606 | +4.4% | 0.00% | 0.0% |
| Q3 2023 | $9,630,759 | -45.0% | 313,910 | -28.2% | 0.00% | -33.3% |
| Q2 2023 | $17,524,614 | +13.4% | 437,350 | +15.5% | 0.00% | 0.0% |
| Q1 2023 | $15,457,930 | -39.6% | 378,778 | -42.9% | 0.00% | -40.0% |
| Q4 2022 | $25,600,824 | -49.7% | 663,062 | -30.7% | 0.01% | -54.5% |
| Q3 2022 | $50,906,000 | +17.5% | 957,068 | +28.8% | 0.01% | +22.2% |
| Q2 2022 | $43,317,000 | -16.1% | 742,989 | +9.9% | 0.01% | 0.0% |
| Q1 2022 | $51,620,000 | +1108.3% | 676,365 | +852.7% | 0.01% | +800.0% |
| Q4 2021 | $4,272,000 | -80.5% | 70,995 | -80.6% | 0.00% | -75.0% |
| Q4 2020 | $21,906,000 | -2.5% | 366,071 | -2.0% | 0.00% | -20.0% |
| Q3 2020 | $22,464,000 | +14.3% | 373,654 | -0.2% | 0.01% | +25.0% |
| Q2 2020 | $19,650,000 | +347.3% | 374,510 | +270.8% | 0.00% | +300.0% |
| Q2 2019 | $4,393,000 | +12.3% | 101,000 | -1.7% | 0.00% | 0.0% |
| Q1 2019 | $3,912,000 | +28.8% | 102,773 | +45.5% | 0.00% | 0.0% |
| Q4 2018 | $3,038,000 | +288.5% | 70,633 | +330.6% | 0.00% | – |
| Q2 2017 | $782,000 | +4.5% | 16,403 | 0.0% | 0.00% | – |
| Q1 2017 | $748,000 | -9.9% | 16,403 | -36.2% | 0.00% | – |
| Q4 2016 | $830,000 | -63.2% | 25,691 | +10.3% | 0.00% | -100.0% |
| Q3 2014 | $2,258,000 | -95.6% | 23,300 | -95.8% | 0.00% | -92.9% |
| Q2 2014 | $50,921,000 | +47.2% | 554,332 | +12.1% | 0.01% | +40.0% |
| Q1 2014 | $34,595,000 | -32.7% | 494,288 | -44.7% | 0.01% | -33.3% |
| Q4 2013 | $51,413,000 | +18.1% | 894,295 | -1.2% | 0.02% | +7.1% |
| Q3 2013 | $43,517,000 | +381.4% | 904,917 | +190.3% | 0.01% | +366.7% |
| Q2 2013 | $9,039,000 | – | 311,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
| GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
| Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
| Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
| AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
| ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
| RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
| Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
| Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
| Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |